Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. market
Portland Business Journals
Global Impact Award: Hemex Health expands detection to underserved countries
IFC Health Newsletter | July 2022
Expert Voices: An Interview with Patti White of Hemex Health
CTIP Pediatric MedTech Accelerator
CTIP Announces 2022 Health Equity FlexGrant Winners
Portland Business Journal
Portland company seeks FDA approval for 15-minute Covid test
NIH: National Heart Blood and Lungs Institute
Future of medicine: Lab-on-a-chip devices starting to make an impact
NIH: Today's Faces of Sickle Cell Disease
Accurate diagnosis by state-of-the-art machine.
Article from The Lok Doot, regional newspaper in India.
ETHealthWorld
We need to shift to a multi-disease approach to ensure that patients are screened for more than one communicable disease: Madhav Joshi, CEO, IHF
Novartis Monacle
Patti White, CEO, and Robin Roberts, Founder of the Novartis Biome, discuss a collaboration to bring diagnostics and therapeutics to Sub Sahara Africa.
360Dx
devex
Global health breakthroughs — other than for COVID-19 — in 2020
Novartis Live.
Biome is taking the fast lane
devex
'Optimized for the underserved': A new diagnostic test built for low-income settings
devex
Can a wave of innovation bring an end to sickle cell disease in sight?
Elevate Capital
Patti White of Hemex Health Shares Her Venture Capital Experience
TechLink
Hemex Health developing malaria detector with Navy researchers in Peru
San Francisco Business Times
In a small San Francisco office, Big Pharma zeroes in on digital health
Medgaget
A SMART Idea: Point-of-Care Diagnostic for Sickle Cell Disease and Malaria (Interview)
Next Billion
Using Mobile Technology to Fight Disease: Three Tips for Social Startups in the Developing World